We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
218 hedge funds and large institutions have $1.13B invested in Amphastar Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 76 increasing their positions, 82 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
285% more call options, than puts
Call options by funds: $2.23M | Put options by funds: $581K
48% more capital invested
Capital invested by funds: $764M → $1.13B (+$368M)
23% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 26
2.76% more ownership
Funds ownership: 60.3% → 63.06% (+2.8%)
2% more funds holding
Funds holding: 213 → 218 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 82
Holders
218
Holders Change
+5
Holders Change %
+2.35%
% of All Funds
3.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
32
Increased
76
Reduced
82
Closed
26
Calls
$2.23M
Puts
$581K
Net Calls
+$1.65M
Net Calls Change
+$628K
Top Buyers
| 1 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$17.6M |
| 2 |
Neuberger Berman Group
New York
|
+$14.1M |
| 3 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$10.2M |
| 4 |
Millennium Management
New York
|
+$8.07M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$7.4M |
Top Sellers
| 1 |
BlackRock
New York
|
-$15.5M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$10.5M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$6.47M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$3.01M |
| 5 |
Morgan Stanley
New York
|
-$2.72M |
